Skip to main content
TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · IEX Real-Time Price · USD
148.97
-1.22 (-0.81%)
At close: Jul 2, 2024, 4:00 PM
149.80
+0.83 (0.56%)
After-hours: Jul 2, 2024, 7:58 PM EDT

TransMedics Group Revenue

TransMedics Group had revenue of $296.92M in the twelve months ending March 31, 2024, with 149.23% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $96.85M with 133.07% year-over-year growth. In the year 2023, TransMedics Group had annual revenue of $241.62M with 158.53% growth.

Revenue (ttm)
$296.92M
Revenue Growth
+149.23%
P/S Ratio
16.53
Revenue / Employee
$508,423
Employees
584
Market Cap
4.91B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 29, 201813.02M5.33M69.38%
Dec 30, 20177.69M1.48M23.77%
Dec 31, 20166.21M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Select Medical Holdings 6.79B
Option Care Health 4.43B
DENTSPLY SIRONA 3.94B
R1 RCM 2.31B
Merit Medical Systems 1.28B
Stevanato Group 1.18B
Doximity 475.42M
BridgeBio Pharma 218.60M
Revenue Rankings

TMDX News

More News